Main > ONCOLOGY (**) > Prostate Cancer MET *** > Treatment > UK. A. BicalutAmide+***

---

UK. A. BicalutAmide+***'s subsections
(*) USA Initial Approval: 1995
+LHRH Analog
Company
Hormone Sensitive Prostate Cancer
Patent>Assignee; Claims; No.; Etc.
Patent>USA Expiration: 2008. 10.01
Stage D2
TradeMark
TradeMark Web-Site

UK. A. BicalutAmide+***'s products
This section has no products